Overview

Ideal Steroids for Asthma Treatment in the PICU

Status:
Enrolling by invitation
Trial end date:
2022-07-21
Target enrollment:
Participant gender:
Summary
Determine if differences in (1) pediatric intensive care unit length of stay, (2) continuous nebulized albuterol duration, and (3) a composite outcome of advanced asthma therapy incidence including use of non-invasive ventilation (NIV), terbutaline, inhaled helium and mechanical ventilation between cohorts of children admitted with status asthmaticus to the PICU treated with either IV dexamethasone (DM) or methylprednisolone (MP).
Phase:
Phase 4
Details
Lead Sponsor:
Johns Hopkins All Children's Hospital
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate